Poggi V, Town M, Foulkes N S, Luzzatto L
Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Biochem J. 1990 Oct 1;271(1):157-60. doi: 10.1042/bj2710157.
We report the characterization at the molecular level of a mutant glucose-6-phosphate dehydrogenase (G6PD) gene in a Greek boy who presented with a chronic non-spherocytic haemolytic anaemia. In order to identify the mutation from a small amount of patient material, we adopted an approach which by-passes the need to construct a library by using the polymerase chain reaction. The entire coding region was amplified in eight sections, with genomic DNA as template. The DNA fragments were then cloned in an M13 vector and sequenced. The only difference from the sequence of normal G6PD was a T----G substitution at nucleotide position 648 in exon 7, which predicts a substitution of leucine for phenylalanine at amino acid position 216. This mutation creates a new recognition site for the restriction nuclease BalI. We confirmed the presence of the mutation in the DNA of the patient's mother, who was found to be heterozygous for the new BalI site. This is the first transversion among the point mutations thus far reported in the human G6PD gene.
我们报告了一名患有慢性非球形红细胞溶血性贫血的希腊男孩中突变型葡萄糖-6-磷酸脱氢酶(G6PD)基因在分子水平上的特征。为了从少量患者材料中鉴定出该突变,我们采用了一种方法,该方法通过使用聚合酶链反应绕过构建文库的需求。以基因组DNA为模板,将整个编码区扩增为八个片段。然后将DNA片段克隆到M13载体中并进行测序。与正常G6PD序列的唯一差异是外显子7中核苷酸位置648处的T→G替换,这预测在氨基酸位置216处亮氨酸替代苯丙氨酸。该突变产生了一种新的限制性核酸酶BalI识别位点。我们证实了患者母亲的DNA中存在该突变,发现她对于新的BalI位点是杂合的。这是迄今为止人类G6PD基因报道的点突变中的首次颠换。